NCT05402956

Brief Summary

In this studly, the effects of an 12-week aerobic exercise training in persons with multiple sclerosis with restless legs syndrome will be investigated.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at P25-P50 for not_applicable multiple-sclerosis

Timeline
Completed

Started May 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 30, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

May 30, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 2, 2022

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

June 6, 2022

Status Verified

June 1, 2022

Enrollment Period

1.3 years

First QC Date

May 30, 2022

Last Update Submit

June 2, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • International Restless Legs Syndrome Study Group rating scale for restless legs syndrome

    The International Restless Legs Syndrome Study Group rating scale for restless legs syndrome is used to assess severity of the restless legs syndrome symptoms. It consists of 10 items scored by 0 to 4. Possible scores range from 0 to 40. Higher scores indicate higher severity.

    Change from Baseline at 12 weeks

Secondary Outcomes (9)

  • Timed 25-Foot Walk

    Change from Baseline at 12 weeks

  • 12-Item Multiple sclerosis walking scale

    Change from Baseline at 12 weeks

  • Epworth Sleepiness Scale

    Change from Baseline at 12 weeks

  • Multiple Sclerosis International Quality of Life questionnaire

    Change from Baseline at 12 weeks

  • Pittsburgh Sleep Quality Index

    Change from Baseline at 12 weeks

  • +4 more secondary outcomes

Other Outcomes (2)

  • Restless Legs Syndrome Diagnostic Criteria

    At Baseline

  • Expanded Disability Status Scale

    At Baseline

Study Arms (2)

Aerobic exercise

EXPERIMENTAL
Behavioral: Aerobic exercise

Control

NO INTERVENTION

Interventions

Moderate aerobic exercise training

Aerobic exercise

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A relapsing-remitting or secondary progressive type of multiple sclerosis,
  • To be willing to participate in the study.

You may not qualify if:

  • Another neurological disorder,
  • Orthopedic surgery history including the ankle-foot, knee, hip, or spine, affecting balance,
  • Diagnosed severe cognitive and/or psychiatric impairment,
  • Having congestive heart failure, coronary, cerebrovascular, and pulmonary disease such as COPD
  • Having cardiac disease such as hypertension that would be a contraindication to exercise

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dokuz Eylul University Hospital, MS Outpatient Clinic

Izmir, 35430, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Multiple Sclerosis

Interventions

Exercise

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Single (Outcomes Assessor)
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Parallel Assignment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

May 30, 2022

First Posted

June 2, 2022

Study Start

May 30, 2022

Primary Completion

October 1, 2023

Study Completion

December 1, 2023

Last Updated

June 6, 2022

Record last verified: 2022-06

Locations